Peng B, Quan Z, Liang L, Liu M, Hu K, Chen S
Sci Rep. 2025; 15(1):7672.
PMID: 40044876
PMC: 11882843.
DOI: 10.1038/s41598-025-92614-4.
Liu W, Chen M, Liu Y, Li X, Li H, Wang J
Front Vet Sci. 2025; 12:1540613.
PMID: 40027357
PMC: 11868070.
DOI: 10.3389/fvets.2025.1540613.
Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A
Cancers (Basel). 2025; 17(4).
PMID: 40002172
PMC: 11853212.
DOI: 10.3390/cancers17040579.
Caragine C, Le V, Mustafa M, Diaz B, Morris J, Muller S
Nat Commun. 2025; 16(1):1611.
PMID: 39948336
PMC: 11825950.
DOI: 10.1038/s41467-025-56568-5.
Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T
Biomedicines. 2025; 12(12.
PMID: 39767566
PMC: 11726849.
DOI: 10.3390/biomedicines12122659.
Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastoma.
Wu Y, Li F, Yang C, Zhang X, Xue Z, Sun Y
Sci Rep. 2025; 15(1):954.
PMID: 39762261
PMC: 11704019.
DOI: 10.1038/s41598-024-82109-z.
Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma.
Sun Z, Du H, Zheng X, Zhang H, Hu H
BMC Med Genomics. 2025; 18(1):3.
PMID: 39754187
PMC: 11697625.
DOI: 10.1186/s12920-024-02081-5.
SE-lncRNAs in Cancer: Classification, Subcellular Localisation, Function and Corresponding TFs.
Bao Y, Teng S, Zhai H, Zhang Y, Xu Y, Li C
J Cell Mol Med. 2024; 28(24):e70296.
PMID: 39690143
PMC: 11652108.
DOI: 10.1111/jcmm.70296.
Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.
Hussain M, Sharma S, Kumari A, Kamran A, Bahl G, Bisht A
Epigenomics. 2024; 16(23-24):1453-1464.
PMID: 39601046
PMC: 11622780.
DOI: 10.1080/17501911.2024.2430170.
DNA regulatory element cooperation and competition in transcription.
Lee H, Friedman M, Kim S, Oh S
BMB Rep. 2024; 57(12):509-520.
PMID: 39523506
PMC: 11693600.
Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer.
Ge X, Shen Z, Yin Y
Cancer Cell Int. 2024; 24(1):369.
PMID: 39522033
PMC: 11549762.
DOI: 10.1186/s12935-024-03549-1.
Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers.
Wang S, Bai Y, Ma J, Qiao L, Zhang M
Front Pharmacol. 2024; 15:1442227.
PMID: 39512820
PMC: 11540796.
DOI: 10.3389/fphar.2024.1442227.
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics.
Pinkney H, Ross C, Hodgson T, Pattison S, Diermeier S
NPJ Precis Oncol. 2024; 8(1):230.
PMID: 39390212
PMC: 11467462.
DOI: 10.1038/s41698-024-00728-1.
Superenhancer-driven circRNA Myst4 involves in pulmonary artery smooth muscle cell ferroptosis in pulmonary hypertension.
He S, Bai J, Zhang L, Yuan H, Ma C, Wang X
iScience. 2024; 27(10):110900.
PMID: 39351203
PMC: 11440257.
DOI: 10.1016/j.isci.2024.110900.
Unraveling the Regulatory Role of HuR/microRNA Axis in Colorectal Cancer Tumorigenesis.
Yadav V, Singh T, Sharma D, Garg V, Chakraborty P, Ghatak S
Cancers (Basel). 2024; 16(18).
PMID: 39335155
PMC: 11430344.
DOI: 10.3390/cancers16183183.
CASCADES, a novel SOX2 super-enhancer-associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma.
Shahzad U, Nikolopoulos M, Li C, Johnston M, Wang J, Sabha N
Mol Oncol. 2024; 19(3):764-784.
PMID: 39323013
PMC: 11887672.
DOI: 10.1002/1878-0261.13735.
Long non‑coding RNAs as diagnostic and prognostic biomarkers for colorectal cancer (Review).
Lin Y, Zhao W, Pu R, Lv Z, Xie H, Li Y
Oncol Lett. 2024; 28(4):486.
PMID: 39185489
PMC: 11342420.
DOI: 10.3892/ol.2024.14619.
The enhancer RNA, AANCR, regulates APOE expression in astrocytes and microglia.
Wan M, Liu Y, Li D, Snyder R, Elkin L, Day C
Nucleic Acids Res. 2024; 52(17):10235-10254.
PMID: 39162226
PMC: 11417409.
DOI: 10.1093/nar/gkae696.
RNA-Independent Regulatory Functions of lncRNA in Complex Disease.
Kafida M, Karela M, Giakountis A
Cancers (Basel). 2024; 16(15).
PMID: 39123456
PMC: 11311644.
DOI: 10.3390/cancers16152728.
CircNAP1L4 regulates pulmonary artery smooth muscle cell proliferation via the NAP1L4-mediated super-enhancer-driven glycolysis gene hexokinase II (HK II) in pulmonary hypertension.
Wang X, Guan X, Zhu X, Zhang L, Ma C, He S
FASEB J. 2024; 38(15):e23868.
PMID: 39102213
PMC: 11607635.
DOI: 10.1096/fj.202400585RRR.